1-Minute Consult

When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?

Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034

Article Information

vol. 91 no. 1 47-51
DOI 
https://doi.org/10.3949/ccjm.91a.23034
PubMed 
38167393
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online January 2, 2024.
Copyright & Usage 
Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Osamah Z. Badwan, MD
  1. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  1. Lorenzo Braghieri, MD
  1. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  1. Warren Skoza, MD
  1. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
  1. Ankit Agrawal, MD
  1. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
  1. Venu Menon, MD
  1. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
  2. Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. W. H. Wilson Tang, MD⇑
  1. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
  2. Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Address:
    W. H. Wilson Tang, MD, Department of Cardiovascular Medicine, J3-4, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; tangw{at}ccf.org

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects